Truzoli Roberto, Reed Phil, Osborne Lisa A
Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy.
Department of Psychology, Swansea University, Swansea, United Kingdom.
Front Med (Lausanne). 2021 Jun 17;8:648403. doi: 10.3389/fmed.2021.648403. eCollection 2021.
Patient engagement with treatments potentially poses problems for interpreting the results and meaning of Randomised Control Trials (RCTs). If patients are assigned to treatments that do, or do not, match their expectations, and this impacts their motivation to engage with that treatment, it will affect the distribution of outcomes. In turn, this will impact the obtained power and error rates of RCTs. Simple Monto Carlo simulations demonstrate that these patient variables affect sample variance, and sample kurtosis. These effects reduce the power of RCTs, and may lead to false negatives, even when the randomisation process works, and equally distributes those with positive and negative views about a treatment to a trial arm.
患者对治疗的参与度可能会给解释随机对照试验(RCT)的结果和意义带来问题。如果患者被分配到符合或不符合其期望的治疗组,而这影响了他们参与该治疗的积极性,那么这将影响结果的分布。反过来,这将影响RCT获得的检验效能和错误率。简单的蒙特卡洛模拟表明,这些患者变量会影响样本方差和样本峰度。这些影响会降低RCT的检验效能,甚至可能导致假阴性结果,即使随机化过程有效,并且将对治疗持正面和负面看法的患者均匀分配到试验组中。